Showing 37,181 - 37,200 results of 226,405 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 2.18s Refine Results
  1. 37181

    Data_Sheet_4_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  2. 37182

    Data_Sheet_1_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  3. 37183

    Data_Sheet_6_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  4. 37184

    Data_Sheet_5_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  5. 37185

    Data_Sheet_2_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  6. 37186

    Data_Sheet_3_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

    Published 2018
    “…These results suggest that the combination of an LRA and an “apoptosis-inducing” agent, such as a Smac mimetic, is a possible treatment option to decrease HIV-1 reservoirs without the occurrence of HIV-1 production by reactivated cells.…”
  7. 37187

    AMF protects against the CYP-induced decreases in taste sensitivity and the number of fungiform papillae with and without pore, and improves overall morphological index of fungifor... by Nabanita Mukherjee (200796)

    Published 2013
    “…The morphological index is expressed as p/P, where p = proper taste buds and P = Total number of taste buds. There was a significant decrease in the morphological index for CYP-injected mice on days 4, 7 and 10 compared to saline controls. …”
  8. 37188
  9. 37189
  10. 37190
  11. 37191

    Table1_Tongue Displacement Device in Decreasing the Radiation Dose to Tongue and Preventing Proton Beam Overshoot in Proton Therapy for Unilateral Head and Neck Cancer.docx by Chae-Seon Hong (4911874)

    Published 2021
    “…The use of scTDD resulted in a statistically significant decrease in the radiation dose to the tongue and COM compared to sMP. …”
  12. 37192
  13. 37193
  14. 37194

    Table2_Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis.docx by Ying Tan (346135)

    Published 2024
    “…According to the subgroup analyses, the combination of AM and ARB seems to be more effective in reducing UAER than the combination of ACEI, and the addition of AM may achieve a more significant clinical effect on decreasing Scr for DKD patients with 24h-UTP>2 g or Scr>110–133 μmol/L and >133 μmol/L. …”
  15. 37195

    Table1_Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis.docx by Ying Tan (346135)

    Published 2024
    “…According to the subgroup analyses, the combination of AM and ARB seems to be more effective in reducing UAER than the combination of ACEI, and the addition of AM may achieve a more significant clinical effect on decreasing Scr for DKD patients with 24h-UTP>2 g or Scr>110–133 μmol/L and >133 μmol/L. …”
  16. 37196

    Table_1_Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions.xlsx by Erin C. Boone (8814977)

    Published 2020
    “…</p>Conclusions<p>Since the “enhancer” SNP can be present on a portion of normal, decreased, or no function alleles, the phase of the “enhancer” SNP must be considered when investigating the impact of the “enhancer” SNP on CYP2D6 activity.…”
  17. 37197

    Image_2_Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort.JPEG by Carlotta Lunghi (2274841)

    Published 2023
    “…Trends over time showed statistically significant increased use of antipsychotics and ADHD medications, decreased use of anxiolytics and mood stabilizers, and a stable use of antidepressants.…”
  18. 37198

    Image_1_Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort.JPEG by Carlotta Lunghi (2274841)

    Published 2023
    “…Trends over time showed statistically significant increased use of antipsychotics and ADHD medications, decreased use of anxiolytics and mood stabilizers, and a stable use of antidepressants.…”
  19. 37199

    Image_1_Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions.pdf by Erin C. Boone (8814977)

    Published 2020
    “…</p>Conclusions<p>Since the “enhancer” SNP can be present on a portion of normal, decreased, or no function alleles, the phase of the “enhancer” SNP must be considered when investigating the impact of the “enhancer” SNP on CYP2D6 activity.…”
  20. 37200

    Table_1_Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort.DOCX by Carlotta Lunghi (2274841)

    Published 2023
    “…Trends over time showed statistically significant increased use of antipsychotics and ADHD medications, decreased use of anxiolytics and mood stabilizers, and a stable use of antidepressants.…”